chemotherapy
GlaxoSmithKline lowers dosage to protect your heart
- Thu, 07/05/2012 - 9:33am
GlaxoSmithKline LLC has lowered Zofran’s dosage label after preliminary results of a clinical study revealed a risk of developing an abnormal heart rhythm.
-
Judge consolidates Wright Conserve hip replacements into MDL
- Mar 16, 2012
-
FDA advisory committee ordered to conduct new Yaz and Yasmin meeting
- Jan 18, 2012
-
Man alleges Actos caused bladder cancer in four months’ time
- Jun 19, 2012
-
Increased blood clot risk associated with newer birth controls
- Jan 5, 2012
-
Johnson & Johnson sued for vaginal mesh complications
- Feb 15, 2012
-
Birth defects caused by antidepressants provoke lawsuit
- Mar 14, 2012
-
FDA issues warning after codeine kills children post-surgery
- Aug 16, 2012
-
Artificial retina gives sight to blind mice
- Aug 16, 2012
-
Lucentis approved for diabetic macular edema
- Aug 14, 2012
-
Mayo Clinic: Patients in the dark about prescriptions
- Aug 9, 2012
-
Hospital's plan to prevent painkiller abuse
- Aug 8, 2012
-
Alzheimer's drug disappoints
- Aug 8, 2012
blood thinner acetaminophen Design Xarelto Avandia MenHibrix Zocor Warfarin Avaira Lexapro diet drug dabigatran Gynecare Prolift venous thromboembolism ADHD pulmonary embolism HIV test Tutorials pulmonary embolism yo Roche EMA Washington Photography hormone replacement therapy settlement fentanyl patch Nesina colon cancer Johnson & Johnson lawsuits
More Dangerous Drug News
Get News Updates By Email
@ConsumerDrugRep Tweets
Archives
- June 2011 (3)
- September 2011 (1)
- October 2011 (3)
- November 2011 (5)
- December 2011 (25)
- January 2012 (8)
- February 2012 (24)
- March 2012 (20)
- April 2012 (6)
- May 2012 (12)